vasoactive-intestinal-peptide has been researched along with Epilepsies--Myoclonic* in 2 studies
2 other study(ies) available for vasoactive-intestinal-peptide and Epilepsies--Myoclonic
| Article | Year |
|---|---|
VIP interneuron impairment promotes in vivo circuit dysfunction and autism-related behaviors in Dravet syndrome.
Dravet syndrome (DS) is a severe neurodevelopmental disorder caused by loss-of-function variants in SCN1A, which encodes the voltage-gated sodium channel subunit Nav1.1. We recently showed that neocortical vasoactive intestinal peptide interneurons (VIP-INs) express Nav1.1 and are hypoexcitable in DS (Scn1a Topics: Animals; Autistic Disorder; Disease Models, Animal; Epilepsies, Myoclonic; Interneurons; Mice; Mice, Transgenic; NAV1.1 Voltage-Gated Sodium Channel; Vasoactive Intestinal Peptide | 2023 |
Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome.
Dravet Syndrome (DS) is a severe neurodevelopmental disorder caused by pathogenic loss of function variants in the gene Topics: Action Potentials; Animals; Brain; Epilepsies, Myoclonic; Interneurons; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NAV1.1 Voltage-Gated Sodium Channel; Vasoactive Intestinal Peptide | 2019 |